Leplow Bernd, Eggebrecht Anna, Pohl Johannes
Department of Psychology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Patient Prefer Adherence. 2017 Sep 14;11:1555-1563. doi: 10.2147/PPA.S141060. eCollection 2017.
Differential effects of botulinum toxin (BoNT) treatment in cervical dystonia (CD) and blepharospasm (BSP) treatment satisfaction and emotional responses to a life with a disabling condition were investigated. Special interest was drawn to the course within a BoNT treatment cycle and the effects of subjective well-being vs perceived intensity of motor symptoms and quality of life.
A questionnaire was distributed among 372 CD patients and 125 BSP patients, recruited from 13 BoNT centers throughout Germany. Items were related to dystonic symptoms, BoNT treatment responses and treatment satisfaction, quality of life, working situation, and emotional reactions to a life with dystonia.
CD patients and BSP patients were widely satisfied with BoNT treatment, but treatment satisfaction worsened significantly within the treatment cycle. Especially CD patients reported that both the dystonic symptoms and the effects of BoNT treatment were influenced by emotional factors. Despite good overall treatment effects, patients from both groups perceived marked persistence of motor symptoms, restrictions of everyday life functions, and reduced quality of life. Functional amelioration of motor symptoms and emotional well-being were only moderately correlated. About 22% of patients from both groups reported mental disorders or emotional disturbances prior to the onset of dystonia.
As numerous psychological factors determine perceived outcome, BoNT treatment should be further improved by patient's education strategies enhancing behavioral self-control. From the patient's perspective, individual intervals, which may avoid exacerbation between injection points, should be considered. Moreover, patients at risk, with reduced adherence and poor BoNT outcome, should be identified and addressed within psychoeducation.
研究了肉毒杆菌毒素(BoNT)治疗对颈部肌张力障碍(CD)和眼睑痉挛(BSP)治疗满意度以及对残疾生活的情绪反应的不同影响。特别关注了BoNT治疗周期内的过程以及主观幸福感与运动症状感知强度和生活质量的影响。
向从德国各地13个BoNT治疗中心招募的372例CD患者和125例BSP患者发放问卷。问卷项目涉及肌张力障碍症状、BoNT治疗反应和治疗满意度、生活质量、工作状况以及对肌张力障碍生活的情绪反应。
CD患者和BSP患者对BoNT治疗普遍满意,但治疗满意度在治疗周期内显著恶化。尤其是CD患者报告说,肌张力障碍症状和BoNT治疗效果均受情绪因素影响。尽管总体治疗效果良好,但两组患者均感觉到运动症状持续存在、日常生活功能受限以及生活质量下降。运动症状的功能改善与情绪幸福感仅呈中度相关。两组中约22%的患者在肌张力障碍发作前报告有精神障碍或情绪障碍。
由于众多心理因素决定了感知结果,应通过加强行为自我控制的患者教育策略进一步改善BoNT治疗。从患者角度来看,应考虑可能避免注射点之间症状加重的个体化间隔时间。此外,应在心理教育中识别并处理有风险、依从性降低且BoNT治疗效果不佳的患者。